Literature DB >> 22700863

Exercise performance and dynamic hyperinflation in lymphangioleiomyomatosis.

Bruno G Baldi1, André L P Albuquerque, Suzana P Pimenta, João M Salge, Ronaldo A Kairalla, Carlos R R Carvalho.   

Abstract

RATIONALE: Lymphangioleiomyomatosis (LAM) is characterized by exercise performance impairment. Although airflow limitation is common, no previous studies have evaluated the prevalence and impact of dynamic hyperinflation (DH) in LAM.
OBJECTIVES: To investigate the dynamic responses during maximal exercise and the prevalence, predictors, and repercussions of DH in LAM.
METHODS: Forty-two patients with LAM performed symptom-limited incremental cycle exercise and pulmonary functions tests (PFTs) and were compared with 10 age-matched healthy women. Dyspnea intensity, inspiratory capacity, oxygen saturation, and cardiac, metabolic, and respiratory variables were assessed during exercise. Patients with LAM also performed a 6-minute walk test (6MWT).
MEASUREMENTS AND MAIN RESULTS: Patients with LAM had higher baseline dyspnea, poorer quality of life, obstructive pattern, air trapping, and reduced diffusing capacity of carbon monoxide in PFTs. Although they had the same level of regular physical activity, their maximal exercise performance was reduced and was associated with ventilatory limitation, greater desaturation, and dyspnea. The prevalence of DH was high in LAM (55%), even in patients with mild spirometric abnormalities, and was correlated with airflow obstruction, air trapping, and diffusing capacity of carbon monoxide. Compared with the non-DH subgroup, the patients who developed DH had a ventilatory limitation contributing to exercise cessation on cycling and higher desaturation and dyspnea intensity during the 6MWT.
CONCLUSIONS: Ventilatory limitation and gas exchange impairment are important causes of exercise limitation in LAM. DH is frequent in LAM, even in patients with mild spirometric abnormalities. DH was associated with the severity of disease, higher dyspnea, and lower oxygen saturation. In the 6MWT, desaturation and dyspnea were greater in patients with DH.

Entities:  

Mesh:

Year:  2012        PMID: 22700863     DOI: 10.1164/rccm.201203-0372OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

1.  A Novel Quantitative Computed Tomographic Analysis Suggests How Sirolimus Stabilizes Progressive Air Trapping in Lymphangioleiomyomatosis.

Authors:  Rahul G Argula; Maria Kokosi; Pechin Lo; Hyun J Kim; James G Ravenel; Cristopher Meyer; Jonathan Goldin; Hye-Seung Lee; Charlie Strange; Francis X McCormack
Journal:  Ann Am Thorac Soc       Date:  2016-03

2.  Evaluation of the extent of pulmonary cysts and their association with functional variables and serum markers in lymphangioleiomyomatosis (LAM).

Authors:  Bruno Guedes Baldi; Mariana Sponholz Araujo; Carolina Salim Gonçalves Freitas; Gustavo Borges da Silva Teles; Ronaldo Adib Kairalla; Olívia Meira Dias; Daniel Antunes Silva Pereira; Suzana Pinheiro Pimenta; Carlos Roberto Ribeiro Carvalho
Journal:  Lung       Date:  2014-09-09       Impact factor: 2.584

3.  EPIDEMIOLOGY, PATHOGENESIS and DIAGNOSIS of LYMPHANGIOLEIOMYOMATOSIS.

Authors:  Angelo M Taveira-DaSilva; Joel Moss
Journal:  Expert Opin Orphan Drugs       Date:  2016-03-07       Impact factor: 0.694

4.  Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations.

Authors:  Carolina Salim Gonçalves Freitas; Bruno Guedes Baldi; Mariana Sponholz Araújo; Glaucia Itamaro Heiden; Ronaldo Adib Kairalla; Carlos Roberto Ribeiro Carvalho
Journal:  J Bras Pneumol       Date:  2015 May-Jun       Impact factor: 2.624

Review 5.  Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis.

Authors:  Angelo M Taveira-DaSilva; Joel Moss
Journal:  Clin Epidemiol       Date:  2015-04-07       Impact factor: 4.790

6.  Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method.

Authors:  Carolina S G Freitas; Bruno G Baldi; Carlos Jardim; Mariana S Araujo; Juliana Barbosa Sobral; Gláucia I Heiden; Ronaldo A Kairalla; Rogério Souza; Carlos R R Carvalho
Journal:  Orphanet J Rare Dis       Date:  2017-04-20       Impact factor: 4.123

7.  Mechanisms of exercise limitation in patients with chronic hypersensitivity pneumonitis.

Authors:  Olívia Meira Dias; Bruno Guedes Baldi; Jeferson George Ferreira; Letícia Zumpano Cardenas; Francesca Pennati; Caterina Salito; Carlos Roberto Ribeiro Carvalho; Andrea Aliverti; André Luis Pereira de Albuquerque
Journal:  ERJ Open Res       Date:  2018-08-22

8.  Effects of yoga on exercise capacity in patients with lymphangioleiomyomatosis: a nonrandomized controlled study.

Authors:  Xiangfeng Li; Wenshuai Xu; Lu Zhang; Yi Zu; Yu Li; Yanli Yang; Ying Xiang; Yun Xiang; Ling Chen; Wei Liu; Lixia Chen; Kai-Feng Xu
Journal:  Orphanet J Rare Dis       Date:  2020-03-16       Impact factor: 4.123

9.  Benefits of pulmonary rehabilitation in patients with advanced lymphangioleiomyomatosis (LAM) compared with COPD - a retrospective analysis.

Authors:  Rainer Gloeckl; Christoph Nell; Tessa Schneeberger; Inga Jarosch; Martina Boensch; Henrik Watz; Hubert Wirtz; Tobias Welte; Klaus Kenn; Andreas Rembert Koczulla
Journal:  Orphanet J Rare Dis       Date:  2020-09-22       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.